Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1.

Boelen L, Debebe B, Silveira M, Salam A, Makinde J, Roberts CH, Wang ECY, Frater J, Gilmour J, Twigger K, Ladell K, Miners KL, Jayaraman J, Traherne JA, Price DA, Qi Y, Martin MP, Macallan DC, Thio CL, Astemborski J, Kirk G, Donfield SM, Buchbinder S, Khakoo SI, Goedert JJ, Trowsdale J, Carrington M, Kollnberger S, Asquith B.

Sci Immunol. 2018 Nov 9;3(29). pii: eaao2892. doi: 10.1126/sciimmunol.aao2892.

PMID:
30413420
2.

Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.

Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, Busch M, Alexander GJ, Rosen HR, Edlin BR, Segal FP, Lauer GM, Thomas DL, Daly MJ, Chung RT, Kim AY.

Sci Rep. 2017 Nov 20;7(1):15843. doi: 10.1038/s41598-017-16011-2.

3.

The importance of genetic factors for the development of arthropathy: a longitudinal study of children and adolescents with haemophilia A.

Gomperts ED, Schwarz J, Donfield SM, Lail AE, Astermark J, Hoots WK, Winkler CA, Berntorp E.

Thromb Haemost. 2017 Jan 26;117(2):277-285. doi: 10.1160/TH16-06-0440. Epub 2016 Dec 8.

PMID:
27929201
4.

Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.

Kahle J, Orlowski A, Stichel D, Healey JF, Parker ET, Donfield SM, Astermark J, Berntorp E, Lollar P, Schwabe D, Königs C.

Haemophilia. 2017 Mar;23(2):292-299. doi: 10.1111/hae.13105. Epub 2016 Nov 8.

PMID:
27862687
5.

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.

Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL.

Ann Intern Med. 2013 Feb 19;158(4):235-45. doi: 10.7326/0003-4819-158-4-201302190-00003.

6.

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Astermark J, Donfield SM, Gomperts ED, Schwarz J, Menius ED, Pavlova A, Oldenburg J, Kessing B, DiMichele DM, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Blood. 2013 Feb 21;121(8):1446-54. doi: 10.1182/blood-2012-06-434803. Epub 2012 Dec 6.

7.

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study Combined Cohort.

Haemophilia. 2013 Jan;19(1):113-8. doi: 10.1111/hae.12004. Epub 2012 Sep 7.

8.

KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection.

Seich Al Basatena NK, Macnamara A, Vine AM, Thio CL, Astemborski J, Usuku K, Osame M, Kirk GD, Donfield SM, Goedert JJ, Bangham CR, Carrington M, Khakoo SI, Asquith B.

PLoS Pathog. 2011 Oct;7(10):e1002270. doi: 10.1371/journal.ppat.1002270. Epub 2011 Oct 13.

9.

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M.

Nature. 2009 Oct 8;461(7265):798-801. doi: 10.1038/nature08463.

10.

Extended IL10 haplotypes and their association with HIV progression to AIDS.

Oleksyk TK, Shrestha S, Truelove AL, Goedert JJ, Donfield SM, Phair J, Mehta S, O'Brien SJ, Smith MW.

Genes Immun. 2009 Jun;10(4):309-22. doi: 10.1038/gene.2009.9. Epub 2009 Mar 19.

11.

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.

Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM.

Hepatology. 2008 Dec;48(6):1769-78. doi: 10.1002/hep.22549.

12.

Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.

Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW.

Int J Immunogenet. 2008 Jun;35(3):255-64. doi: 10.1111/j.1744-313X.2008.00770.x.

13.

Value added: increasing the power to assess treatment outcome in joint haemorrhages.

Donfield SM, Astermark J, Lail AE, Gilbert SA, Berntorp E; Fenoc Study Group.

Haemophilia. 2008 Mar;14(2):276-80. doi: 10.1111/j.1365-2516.2007.01638.x. Epub 2008 Jan 8.

PMID:
18194307
14.

Platelet count is associated with plasma HIV type 1 RNA and disease progression.

Rieg G, Yeaman M, Lail AE, Donfield SM, Gomperts ED, Daar ES; Hemophilia Growth and Development Study (HGDS).

AIDS Res Hum Retroviruses. 2007 Oct;23(10):1257-61.

PMID:
17961113
15.

Delays in maturation among adolescents with hemophilia and a history of inhibitors.

Donfield SM, Lynn HS, Lail AE, Hoots WK, Berntorp E, Gomperts ED; Hemophilia Growth and Development Study Group.

Blood. 2007 Nov 15;110(10):3656-61. Epub 2007 Aug 22.

16.

Baseline HIV type 1 coreceptor tropism predicts disease progression.

Daar ES, Kesler KL, Petropoulos CJ, Huang W, Bates M, Lail AE, Coakley EP, Gomperts ED, Donfield SM; Hemophilia Growth and Development Study.

Clin Infect Dis. 2007 Sep 1;45(5):643-9. Epub 2007 Jul 20. Erratum in: Clin Infect Dis. 2007 Dec 15;45(12):1656.

PMID:
17683002
17.

Long-term major joint outcomes in young adults with haemophilia: interim data from the HGDS.

Su Y, Wong WY, Lail A, Donfield SM, Konzal S, Gomperts E; Hemophilia Growth And Development Study.

Haemophilia. 2007 Jul;13(4):387-90.

PMID:
17610553
18.

The parachute must be properly folded ...

Donfield SM, Shapiro AD, Gomperts ED, Lynn HS, Usner DW.

J Thromb Haemost. 2007 Mar;5(3):646-7. Epub 2006 Nov 9. No abstract available.

19.

Hepatitis C virus infection and neurocognitive function.

Soogoor M, Lynn HS, Donfield SM, Gomperts E, Bell TS, Daar ES; Hemophilia Growth and Development Study.

Neurology. 2006 Oct 24;67(8):1482-5.

PMID:
17060580
20.

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study.

Astermark J, Donfield SM, DiMichele DM, Gringeri A, Gilbert SA, Waters J, Berntorp E; FENOC Study Group.

Blood. 2007 Jan 15;109(2):546-51. Epub 2006 Sep 21.

21.

Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.

Daar ES, Lynn HS, Donfield SM, Lail A, O'Brien SJ, Huang W, Winkler CA; Hemophilia Growth and Development Study.

J Infect Dis. 2005 Nov 1;192(9):1597-605. Epub 2005 Sep 30.

PMID:
16206074
22.

Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.

Berntorp E, Astermark J, Donfield SM, Nelson GW, Oldenburg J, Shapiro AD, Dimichele DM, Ewenstein BM, Gomperts ED, Winkler CA; Hemophilia Inhibitor Genetics Study.

Haemophilia. 2005 Jul;11(4):427-9. No abstract available.

PMID:
16011603
23.

Haemophilia-related morbidity and quality-of-life.

Donfield SM, Shapiro AD, Gomperts ED, Lynn HS.

Haemophilia. 2005 Jul;11(4):418. No abstract available.

PMID:
16011599
24.

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance.

Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW.

Genes Immun. 2005 Jun;6(4):347-57.

PMID:
15815689
25.

Frequency and causes of hospitalization in HIV-negative children and adolescents with haemophilia A or B and its effect on academic achievement.

Wong WY, Donfield SM, Rains E, FitzGerald G, Pearson SK, Gomperts ED; Hemophilia Growth and Development Study.

Haemophilia. 2004 Jan;10(1):27-33.

PMID:
14962217
26.

Surveillance of infectious complications associated with central venous access devices in children with haemophilia.

Tarantino MD, Lail A, Donfield SM, Lynn H, Peddle L, Hunsberger S, Shapiro AD.

Haemophilia. 2003 Sep;9(5):588-92.

PMID:
14511299
27.

Quantifying practice effects in longitudinal research with the WISC-R and WAIS-R: a study of children and adolescents with hemophilia and male siblings without hemophilia.

Sirois PA, Posner M, Stehbens JA, Loveland KA, Nichols S, Donfield SM, Bell TS, Hill SD, Amodei N; Hemophilia Growth and Development Study.

J Pediatr Psychol. 2002 Mar;27(2):121-31.

PMID:
11821496
28.

Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study.

Shapiro AD, Donfield SM, Lynn HS, Cool VA, Stehbens JA, Hunsberger SL, Tonetta S, Gomperts ED; Academic Achievement in Children with Hemophilia Study Group.

Pediatrics. 2001 Dec;108(6):E105.

PMID:
11731632
29.
30.

The effect of plasma human immunodeficiency virus RNA and CD4(+) T lymphocytes on growth measurements of hemophilic boys and adolescents.

Hilgartner MW, Donfield SM, Lynn HS, Hoots WK, Gomperts ED, Daar ES, Chernoff D, Pearson SK; Hemophilia Growth and Development Study.

Pediatrics. 2001 Apr;107(4):E56.

PMID:
11335777
31.

Incidence of focal white matter lesions in a population of hemophiliac children and their normal siblings. Hemophilia Growth and Development Study.

Nelson MD Jr, Wilson DA, Kisker CT, Evatt BL, Fenstermacher MJ, Lynn HS, Donfield SM, Maeder MA.

Pediatr Radiol. 2000 Oct;30(10):705-9.

PMID:
11075607
32.

Changes in hepatitis B serologic titers in HIV+ and HIV- children with haemophilia.

Kisker CT, Mahoney EM, Arkin S, Maeder MA, Donfield SM, Evatt BL.

Haemophilia. 1999 Sep;5(5):354-9.

PMID:
10583518
33.

HIV-associated immune dysfunction and delayed pubertal development in a cohort of young hemophiliacs. Hemophilia Growth and Development Study.

Mahoney EM, Donfield SM, Howard C, Kaufman F, Gertner JM.

J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):333-7.

PMID:
10428113
34.

Hemophilia morbidity, cognitive functioning, and academic achievement.

Usner DW, Donfield SM, Sirois PA, Gomperts ED, Bale JF Jr, Mitchell WG.

J Pediatr. 1998 Dec;133(6):782-7.

PMID:
9842044
35.

Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally. Hemophilia Growth and Development Study.

Donfield SM, Mahoney EM, Maeder MA, Hawk SM, Sirois PA, Pearson SK, Goldberg IA, Richard SK, Baird-Cox KA, Hoel LN, Cool VA.

Control Clin Trials. 1998 Oct;19(5):451-60.

PMID:
9741866
36.

Progression to AIDS.

Donfield SM, Lynn HS, Hilgartner MW.

Science. 1998 Jun 19;280(5371):1819-20. No abstract available.

PMID:
9669928
37.

Hemophilia growth and development study: relationships between neuropsychological, neurological, and MRI findings at baseline.

Sirois PA, Usner DW, Hill SD, Mitchell WG, Bale JF Jr, Loveland KA, Stehbens JA, Donfield SM, Maeder MA, Amodei N, Contant CF Jr, Nelson MD Jr, Willis JK.

J Pediatr Psychol. 1998 Feb;23(1):45-56.

PMID:
9564128
38.

Longitudinal neurological follow-up of a group of HIV-seropositive and HIV-seronegative hemophiliacs: results from the hemophilia growth and development study.

Mitchell WG, Lynn H, Bale JF Jr, Maeder MA, Donfield SM, Garg B, Tilton AH, Willis JK, Bohan TP.

Pediatrics. 1997 Nov;100(5):817-24.

PMID:
9346981
39.

Growth hormone secretion in HIV-positive versus HIV-negative hemophilic males with abnormal growth and pubertal development. The Hemophilia Growth and Development Study.

Ratner Kaufman F, Gertner JM, Sleeper LA, Donfield SM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):137-44.

PMID:
9241113
40.

Ethics of AIDS study.

Gomperts ED, Donfield SM.

Science. 1996 Dec 6;274(5293):1596b. No abstract available.

PMID:
17842242
41.

Ethics of AIDS study.

Gomperts ED, Donfield SM.

Science. 1996 Dec 6;274(5293):1596. No abstract available.

PMID:
8984621
42.

Evidence for a shift from a type I lymphocyte pattern with HIV disease progression. Hemophilia Growth and Development Study.

Jason J, Sleeper LA, Donfield SM, Murphy J, Warrier I, Arkin S, Evatt B.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 1;10(4):471-6.

PMID:
7583444
43.

Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study.

Gertner JM, Kaufman FR, Donfield SM, Sleeper LA, Shapiro AD, Howard C, Gomperts ED, Hilgartner MW.

J Pediatr. 1994 Jun;124(6):896-902.

PMID:
8201473
44.

Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Hemophilia Growth and Development Study Group.

Jason J, Murphy J, Sleeper LA, Donfield SM, Warrier I, Arkin S, Evatt B, Gomperts ED.

Am J Hematol. 1994 May;46(1):29-35.

PMID:
8184874
45.

Hemophilia growth and development study. Design, methods, and entry data.

Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr, Evatt BL, Gomperts ED, Hoots WK, Jason J, Loveland KA, McKinlay SM, et al.

Am J Pediatr Hematol Oncol. 1993 May;15(2):208-18.

PMID:
8498644
46.

Brain abnormalities in male children and adolescents with hemophilia: detection with MR imaging. The Hemophilia Growth and Development Study Group.

Wilson DA, Nelson MD Jr, Fenstermacher MJ, Bohan TP, Hopper KD, Tilton A, Mitchell WG, Contant CF Jr, Maeder MA, Donfield SM, et al.

Radiology. 1992 Nov;185(2):553-8.

PMID:
1410372
47.

Physical activity by socioeconomic status in two population based cohorts.

Cauley JA, Donfield SM, Laporte RE, Warhaftig NE.

Med Sci Sports Exerc. 1991 Mar;23(3):343-51.

PMID:
2020273

Supplemental Content

Loading ...
Support Center